{"database": "openregs", "table": "documents", "rows": [["FDA-2023-N-3392-0045", "FDA", "FDA-2023-N-3392", "Reference 43 - Kim D., W. Namen Ii, J. Moore, et al., \u201cClinical Assessment of a Biofilm-disrupting Agent for the Management of Chronic Wounds Compared With Standard of Care: A Therapeutic Approach,\u201d Wounds", "Supporting & Related Material", "Background Material", "2023-12-07T05:00:00Z", 2023, 12, null, null, "2023-12-07T23:16:12Z", null, 0, 0, "090000648630cc36"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2023-N-3392-0045"], "units": {}, "query_ms": 0.38991705514490604, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}